Eligibility for anti-TNFα therapy in a psoriatic arthritis out patient cohort

被引:0
作者
Kyle, SD [1 ]
Solanki, K [1 ]
Carmichael, C [1 ]
McHugh, NJ [1 ]
机构
[1] Royal Natl Hosp Rheumat Dis, Bath BA1 1RL, Avon, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
272
引用
收藏
页码:I114 / I114
页数:1
相关论文
共 50 条
  • [41] TNF involvement and anti-TNF therapy of reactive and unclassified arthritis
    Meador, R
    Hsia, E
    Kitumnuaypong, T
    Schumacher, HR
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2002, 20 (06) : S130 - S134
  • [42] LENGTHENING OF RECOMMENDED DOSE RANGE OF ANTI-TNF THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS AND PERIPHERAL PSORIATIC ARTHRITIS IN REMISSION
    Cornejo Piquer, C. Nunez
    Chalmeta Verdejo, I.
    Molina Almela, C.
    Martinez Cordellat, I.
    Feced Olmos, C.
    Grau, E.
    Alcaniz Escandell, C.
    Gonzalez Puig, L.
    Ivorra Cortes, J.
    Negueroles Albuixech, R.
    Munoz Guillen, M. L.
    Valero Sanz, J. L.
    Roman Lvorra, J. A.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 929 - 929
  • [43] TWEAK-binding autoantibodies are generated during psoriatic arthritis and are not influenced by anti-TNF therapy
    Guis, Sandrine
    Berbis, Philippe
    Stephan, Delphine
    Bertin, Daniel
    Amatore, Florent
    Balandraud, Nathalie
    Lesavre, Nathalie
    Desplat-Jego, Sophie
    JOURNAL OF TRANSLATIONAL MEDICINE, 2016, 14
  • [44] Effects of anti-TNF therapy on glucose metabolism in patients with ankylosing spondylitis, psoriatic arthritis or juvenile idiopathic arthritis
    Pires da Silva, Barbara Santos
    Bonfa, Eloisa
    Bertacini de Moraes, Julio Cesar
    Schain Saad, Carla Goncalves
    de Medeiros Ribeiro, Ana Cristina
    Goncalves, Celio Roberto
    de Carvalho, Jozelio Freire
    BIOLOGICALS, 2010, 38 (05) : 567 - 569
  • [45] TWEAK-binding autoantibodies are generated during psoriatic arthritis and are not influenced by anti-TNF therapy
    Sandrine Guis
    Philippe Berbis
    Delphine Stephan
    Daniel Bertin
    Florent Amatore
    Nathalie Balandraud
    Nathalie Lesavre
    Sophie Desplat-Jégo
    Journal of Translational Medicine, 14
  • [46] Neurological symptoms in a patient on anti-TNF therapy, methotrexate and prednisolone for rheumatoid arthritis
    Bach, M.
    Schob, S.
    Baerwald, C.
    INTERNIST, 2020, 61 (03): : 313 - 320
  • [47] PATIENT EXPERIENCE WITH SUBCUTANEOUS ANTI-TNF THERAPY AMONG RHEUMATOID ARTHRITIS PATIENTS
    Tandon, N.
    Bolge, S.
    Annunziata, K.
    VALUE IN HEALTH, 2011, 14 (03) : A134 - A134
  • [48] Safety of Anti-TNF Alpha Agents in the Pregnant Psoriatic Patient
    Shallcross, Laurie K.
    Driscoll, Marcia S.
    CURRENT DRUG THERAPY, 2013, 8 (01) : 45 - 58
  • [49] Systemic Tuberculosis in a Patient on Anti-TNF Therapy
    Trivedi, P.
    Magh, A.
    Adial, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [50] Role of the complement system in rheumatoid arthritis and psoriatic arthritis: Relationship with anti-TNF inhibitors
    Ballanti, Eleonora
    Perricone, Carlo
    di Muzio, Gioia
    Kroegler, Barbara
    Chimenti, Maria Sole
    Graceffa, Dario
    Perricone, Roberto
    AUTOIMMUNITY REVIEWS, 2011, 10 (10) : 617 - 623